Abiopharma

New Form 8-K - EXAGEN INC. Filed: 2025-05-09 AccNo: 0001193125-25-116881 Size: 151 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - AMEDISYS INC Filed: 2025-05-09 AccNo: 0000896262-25-000047 Size: 5 KB

New Form S-8 - Rallybio Corp Filed: 2025-05-09 AccNo: 0001739410-25-000069 Size: 88 KB

New Form DEFR14A - Taysha Gene Therapies, Inc. Filed: 2025-05-09 AccNo: 0001193125-25-116882 Size: 239 KB

New Form 20-F - TC BioPharm Filed: 2025-05-09 AccNo: 0001641172-25-009445 Size: 11 MB

New Form 10-Q - Silo Pharma, Inc. Filed: 2025-05-09 AccNo: 0001213900-25-041519 Size: 4 MB

New Form 10-Q - ENZON PHARMACEUTICALS, INC. Filed: 2025-05-09 AccNo: 0001410578-25-001164 Size: 2 MB

New Form 10-Q - MAIA Biotechnology, Inc. Filed: 2025-05-09 AccNo: 0000950170-25-068005 Size: 6 MB

New Form S-1 - Innovative Eyewear Inc Filed: 2025-05-09 AccNo: 0001829126-25-003518 Size: 724 KB

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Vericel Corp Filed: 2025-05-09 AccNo: 0001140361-25-018156 Size: 8 KB

New Form DEF 14A - enGene Holdings Inc. Filed: 2025-05-09 AccNo: 0001140361-25-018155 Size: 1 MB